Voretigene Neparvovec-rzyl (Luxturna) — CPB 0927 | AETNA Coverage Update

Aetna modified CPB 0927 for voretigene neparvovec-rzyl (Luxturna), effective September 26, 2025. Here's what billing teams need to know before submitting claims.

Aetna, a CVS Health company, updated its Luxturna coverage policy under CPB 0927 Aetna system. This gene therapy treats bi-allelic RPE65 mutation-associated retinal dystrophy — a rare inherited blindness condition. The primary billing code is HCPCS J3398, and the procedure codes include 0810T for subretinal injection. If your practice or facility handles retinal gene therapy, this policy change deserves your full attention before September 26, 2025.

Quick-Reference Table

Aetna Luxturna Coverage Criteria and Medical Necessity Requirements 2025

The Aetna Luxturna coverage policy under CPB 0927 covers voretigene neparvovec-rzyl when specific medical necessity criteria are met. The primary covered diagnosis is bi-allelic RPE65 mutation-associated retinal dystrophy, coded as ICD-10-CM H35.50.

Medical necessity documentation must support the diagnosis. That means genetic testing confirming bi-allelic RPE65 mutations — billed with CPT 81406 (molecular pathology, Level 7) or CPT 81434 (hereditary retinal disorders panel). Without confirmed genetic documentation in the claim file, you're headed toward a claim denial before the chart even gets reviewed.

Precertification of voretigene neparvovec-rzyl is required for all Aetna participating providers and members in applicable plan designs. This is a non-negotiable step. Call (866) 752-7021 or fax the prior authorization request to (888) 267-3277. Statement of Medical Necessity forms are available through Aetna's Specialty Pharmacy Precertification portal.

Don't treat prior authorization as a formality here. Luxturna's list price exceeds $425,000 per eye. Aetna will scrutinize every element of the medical necessity documentation. Gaps in your clinical record — missing visual function tests, incomplete genetic confirmation, or absent prior treatment history — will slow authorization and risk denial.

Whether Luxturna reimbursement flows through the medical benefit or pharmacy benefit depends on the member's plan design. Bill HCPCS J3398 (injection, voretigene neparvovec-rzyl, 1 billion vector genome) for the drug itself. The administration is billed with CPT 0810T — the subretinal injection code that includes vitrectomy and retinotomy. These two codes work together. Missing either one leaves money on the table or creates a mismatched claim.

Aetna Luxturna Site-of-Care Requirements and GCIT Network Restrictions

This is where the CPB 0927 coverage policy gets operationally complex. Unless a member's health plan has specifically opted out of the requirement, Luxturna must be administered at an Aetna Institutes® Gene Based, Cellular and Other Innovative Therapy (GCIT®) Network designated facility.

This is not a suggestion. If your facility is not GCIT-designated, the claim will not be covered — regardless of how solid your medical necessity documentation is. The real issue here is that many retinal surgery centers assume their credentials are sufficient. They're not. GCIT designation is a separate credentialing pathway.

Check the Aetna Institutes® GCIT Designated Networks list before scheduling any patient for Luxturna. If your facility isn't on the list, you have two options: refer the patient to a designated center, or begin the GCIT designation process — which takes time. Don't wait until you have a patient in queue to figure this out.

For billing teams at non-designated centers that administer Luxturna anyway, the financial exposure is significant. You're looking at a complete claim denial on a six-figure drug, with no clean path to appeal on site-of-care grounds if the requirement was in force for that member's plan. Talk to your compliance officer before proceeding if there's any uncertainty about your facility's GCIT status.

Coverage Indications at a Glance

Aetna Luxturna Billing Guidelines and Action Items 2025

If you're billing at a specialty pharmacy level or a hospital outpatient department, confirm with your billing consultant which revenue codes pair with J3398 on a UB-04. Luxturna billing guidelines differ between the professional and facility sides, and the GCIT requirement adds a layer that most standard facility billing workflows don't account for automatically.

CPT, HCPCS, and ICD-10 Codes for Voretigene Neparvovec-rzyl Under CPB 0927

HCPCS Code — Covered When Selection Criteria Are Met

CPT Codes Related to CPB 0927

Key ICD-10-CM Diagnosis Code